SEC Company Response from Cue Biopharma, Inc. (CUE) (CIK 0001645460) (CUE) — Jul 17, 2018

Cue Biopharma, Inc. (CUE) (CIK 0001645460)
Date: July 17, 2018 · CIK: 0001645460 · Accession: 0001193125-18-219367

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-225800

Date

July 17, 2018

Author

/s/ Daniel R. Passeri

Form

CORRESP

Company

Cue Biopharma, Inc. (CUE) (CIK 0001645460)

Letter

Acceleration Request

Cue Biopharma, Inc.

675 W. Kendall Street

Cambridge, MA 02142

July 17, 2018

VIA EDGAR

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Abigail Jacobs

Re: Cue Biopharma, Inc.

Registration Statement on Form S-1

File No. 333-225800

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, registrant Cue Biopharma, Inc. (the “Company”) hereby respectfully requests that the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) be declared effective at 4:00 p.m., Eastern Time, on Thursday, July 19, 2018, or as soon thereafter as is practicable.

Please direct any questions regarding this request to Mark R. Busch ((704) 331-7440; mark.busch@klgates.com) of K&L Gates LLP. In addition, please notify Mr. Busch when this request for acceleration has been granted.

Sincerely,
/s/ Daniel R. Passeri

Show Raw Text

CORRESP
1
filename1.htm

Acceleration Request

 Cue Biopharma, Inc.

675 W. Kendall Street

 Cambridge, MA 02142

July 17, 2018

 VIA EDGAR

Securities and Exchange Commission

 100 F Street, N.E.

Washington, D.C. 20549

 Attention: Abigail Jacobs

Re:
Cue Biopharma, Inc.

Registration Statement on Form S-1

File No. 333-225800

 Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, registrant Cue Biopharma, Inc. (the “Company”) hereby respectfully requests
that the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) be declared effective at 4:00 p.m., Eastern Time, on Thursday, July 19, 2018, or as soon thereafter as
is practicable.

 Please direct any questions regarding this request to Mark R. Busch ((704) 331-7440;
mark.busch@klgates.com) of K&L Gates LLP. In addition, please notify Mr. Busch when this request for acceleration has been granted.

 Sincerely,

/s/ Daniel R. Passeri

 Daniel R. Passeri

Chief Executive Officer

SecProbe.io